Hydrochlorothiazide NDC 42708-027

NDC codes

FDA NDC Directory

Product NDC (as listed)42708-027Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42708-0027Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42708-027-30	42708002730	30 CAPSULE, GELATIN COATED in 1 BOTTLE (42708-027-30)Marketed from Mar 14, 2018 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hydrochlorothiazide
Generic name (nonproprietary): hydrochlorothiazide
Active ingredients: Hydrochlorothiazide — 12.5 mg/1
Dosage form: Capsule, Gelatin coated
Route: Oral
Labeler: QPharma, Inc.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 020504
Marketing start: Dec 27, 1996
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 42708-027_45b3f838-dc1b-489f-e063-6294a90a55c2SPL ID 45b3f838-dc1b-489f-e063-6294a90a55c2SPL set ID 5bacc909-6b02-4815-85ef-55fd25b1b1f7RxCUI 199903UNII 0J48LPH2TH
Pharmacologic class: Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442708002730 followed by a unit qualifier and the quantity

Package 42708-0027-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 5, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hydrochlorothiazide is indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. Unlike potassium sparing combination diuretic products, hydrochlorothiazide may be used in those patients in whom the development of hyperkalemia cannot be risked, including patients taking ACE inhibitors. Usage in Pregnancy: The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. Edema durin…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020504

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020504
Product	Strength	Form · route	Labeler	Product NDC
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	Capsule, Gelatin coatedOral	Aphena Pharma Solutions - Tennessee, LLC	67544-739
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	Capsule, Gelatin coatedOral	Actavis Pharma, Inc.	0591-0347
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	Capsule, Gelatin coatedOral	Proficient Rx LP	63187-548